Alternatives to BC Platforms
Compare BC Platforms alternatives for your business or organization using the curated list below. SourceForge ranks the best alternatives to BC Platforms in 2026. Compare features, ratings, user reviews, pricing, and more from BC Platforms competitors and alternatives in order to make an informed decision for your business.
-
1
SYNTHIA Retrosynthesis Software
Merck KGaA
Expert-coded by chemists and engineered by computer scientists, SYNTHIA™ Retrosynthesis Software enables scientists to quickly find and easily navigate innovative and novel pathways for novel and published target molecules. Quickly and efficiently scan hundreds of pathways to help you identify the best option according to your needs. Explore the most cost-effective routes to your target molecules with state of the art visualization and filtering options. Easily customize search parameters to eliminate or promote reactions, reagents or classes of molecules. Explore unique and innovative syntheses that may be unknown for building your desired molecule. Easily generate a list of commercially available starting materials for your synthesis. Benefit from ISO/IEC 27001 Information Security Certification to guarantee the confidentiality, integrity, and protection of your data.Starting Price: €0 / 30 days -
2
Labguru
Cenevo
Labguru is a secure, cloud-based Electronic Lab Notebook (ELN), LIMS and informatics platform which offers a complete solution for life science research and industry. It records and manages laboratory data and inventory, includes molecular biology tools and chemistry tools, enables automation of the lab, insight into lab data making labs run more efficiently. With Labguru, scientists can design experiments and workflows, capture structured and unstructured data, manage projects, and share their work. Customizable experiment templates, integration of protocols, SOPs, and other cutting-edge features help to increase data quality, streamline workflows and reduce costs. Labguru is available on desktops and mobile devices via the cloud. Labguru is part of Holtzbrinck Publishing Group and serves over 100,000 scientists worldwide from startups, universities, research institutes up to some of the largest pharma companies. -
3
PHEMI Health DataLab
PHEMI Systems
The PHEMI Trustworthy Health DataLab is a unique, cloud-based, integrated big data management system that allows healthcare organizations to enhance innovation and generate value from healthcare data by simplifying the ingestion and de-identification of data with NSA/military-grade governance, privacy, and security built-in. Conventional products simply lock down data, PHEMI goes further, solving privacy and security challenges and addressing the urgent need to secure, govern, curate, and control access to privacy-sensitive personal healthcare information (PHI). This improves data sharing and collaboration inside and outside of an enterprise—without compromising the privacy of sensitive information or increasing administrative burden. PHEMI Trustworthy Health DataLab can scale to any size of organization, is easy to deploy and manage, connects to hundreds of data sources, and integrates with popular data science and business analysis tools. -
4
Scitara DLX
Scitara
Scitara DLX™ offers a rapid connectivity infrastructure for any instrument in the life science laboratory in a fully compliant and auditable cloud-based platform. Scitara DLX™ is a universal digital data infrastructure that connects any instrument, resource, app and software in the laboratory. The cloud-based, fully auditable platform connects all data sources across the lab, allowing the free flow of data across multiple end points. This allows scientists to devote their time to scientific research, not waste it solving data issues. DLX curates and corrects data in flight to support the development of accurate, properly structured data models that feed AI and ML systems. This supports a successful digital transformation strategy in the pharma and biopharma industries. Unlocking insights from scientific data enables faster decision-making in drug discovery and development, helping bring drugs to market more quickly. -
5
Dotmatics
Dotmatics
Dotmatics is the global leader in R&D scientific software that connects science, data, and decision-making. Combining a workflow and data platform with best-of-breed applications, we offer the first true end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more. Trusted by more than 2 million researchers from the world’s leading biopharma, chemicals and materials enterprises, and academic institutions, we are dedicated to working with the scientific community to help make the world a healthier, cleaner and safer place to live. Learn more about our platform and products, including GraphPad Prism, Geneious, SnapGene, Protein Metrics, LabArchives, and more. -
6
BenevolentAI
BenevolentAI
BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates. -
7
Metabolon
Metabolon
At Metabolon, we offer the largest Level 1 library in the metabolomics industry. Our proprietary library has been built and curated over 20 years and contains over 5,400 entries. The vast majority of entries in our library are Level 1 attributing approximately 85% (~4,600 entries); however, some are Level 2 (approximately 15% accounting for around 800 entries) due to a lack of commercial standards available to qualify for Level 1. Metabolon delivers accurate, highly actionable insights for our clients’ scientific or clinical inquiries due to our unmatched library breadth and industry-leading annotation confidence levels. Metabolomics applies to a wide range of research, from soil health to food nutrition and preclinical research to clinical trials. Whether you’re searching for trends in a group or refining an individual’s treatment, metabolomics can help you find answers to important questions. -
8
Scispot
Scispot
Scispot powers life science labs with a unified LabOS™ platform, combining ELN, LIMS, SDMS, QMS, and AI in one configurable, no-code system. Built for CROs, Molecular Diagnostics, Pathology, Pharma QC, and Drug Discovery, Scispot streamlines sample management, inventory automation, and regulatory compliance. Connect with 200+ lab instruments and thousands of apps to eliminate data silos while maintaining FDA 21 CFR Part 11, GxP, GDPR, and HIPAA compliance. Scispot's AI tools transform experimental data into actionable insights, with flexible workflows that adapt as research evolves—without IT support. Trusted by 1000+ scientists globally, Scispot enables rapid deployment so teams focus on science, not administration. Accelerate discoveries, ensure compliance, and scale operations with a platform purpose-built for modern biotech innovation. -
9
Schrödinger
Schrödinger
Transform drug discovery and materials research with advanced molecular modeling. Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space. Our platform is deployed by industry leaders worldwide for drug discovery, as well as for materials science in fields as diverse as aerospace, energy, semiconductors, and electronics displays. The platform powers our own drug discovery efforts, from target identification to hit discovery to lead optimization. It also drives our research collaborations to develop novel medicines for critical public health needs. With more than 150 Ph.D. scientists on our team, we invest heavily in R&D. We’ve published over 400 peer-reviewed papers that demonstrate the strength of our physics-based approaches, and we’re continually pushing the limits of computer modeling. -
10
Atomwise
Atomwise
We use our AI engine to transform drug discovery. Our discoveries help create better medicines faster. Our AI-enabled discovery portfolio includes wholly-owned and co-developed pipeline assets, and is backed by prominent investors. Atomwise developed a machine-learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small-molecule medicines. The secret to reinventing drug discovery with AI is people. We are dedicated to developing the best AI platform and using it to transform small molecule drug discovery. We have to tackle the most challenging, seemingly impossible targets and streamline the drug discovery process to give drug developers more shots on goal. Computational efficiency enables screening of trillions of compounds in silico, increasing the likelihood of success. Demonstrated exquisite model accuracy, overcoming the challenge of false positives. -
11
Eidogen-Sertanty Target Informatics Platform (TIP)
Eidogen-Sertanty
Eidogen-Sertanty's Target Informatics Platform (TIP) is the world's first structural informatics system and knowledgebase that enables researchers with the ability to interrogate the druggable genome from a structural perspective. TIP amplifies the rapidly expanding body of experimental protein structure information and transforms structure-based drug discovery from a low-throughput, data-scarce discipline into a high-throughput, data-rich science. Designed to help bridge the knowledge gap between bioinformatics and cheminformatics, TIP supplies drug discovery researchers with a knowledge base of information that is both distinct from and highly complementary to information furnished by existing bio- and cheminformatics platforms. TIP's seamless integration of structural data management technology with unique target-to-lead calculation and analysis capabilities enhances all stages of the discovery pipeline. -
12
Recursion
Recursion
Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models. -
13
DNAnexus Apollo
DNAnexus
DNAnexus Apollo™ accelerates precision drug discovery by unlocking the power of collaboration to draw critical insights from omics data. Precision drug discovery requires collecting and analyzing huge volumes of omics and clinical data. These datasets are incredibly rich resources, but most legacy and home-grown informatics tools can't cope with their size and complexity. Precision medicine programs can also be hampered by siloed data sources, underpowered collaboration tools, and the burden of complex and always changing regulatory and security requirements. DNAnexus Apollo™ supports precision drug discovery programs by empowering scientists and clinicians to explore and analyze omics and clinical data together, in a single environment, built on a robust, scalable cloud platform. Apollo lets them share data, tools, and analyses easily and securely with peers and collaborators everywhere - whether they're on another floor, or another continent. -
14
AIDDISON
Merck KGaA
AIDDISON™ drug discovery software combines the power of artificial intelligence (AI), machine learning (ML), and 3D computer-aided drug design (CADD) methods to act as a valuable toolkit for medicinal chemistry needs. As a unified platform for efficient and effective ligand-based and structure-based drug design, it integrates all the facets for virtual screening and supports methods for in-silico lead discovery and lead optimization. -
15
GPT-Rosalind
OpenAI
GPT-Rosalind is a purpose-built frontier reasoning model developed by OpenAI to accelerate scientific research across biology, drug discovery, and translational medicine. It is designed specifically for life sciences workflows, where researchers must navigate large volumes of literature, experimental data, and specialized databases to generate and validate new ideas. It combines deep domain understanding in areas such as chemistry, genomics, protein engineering, and disease biology with advanced tool-use capabilities, allowing it to interact with scientific databases, analyze experimental outputs, and support complex, multi-step reasoning tasks. It can assist with evidence synthesis, hypothesis generation, literature review, sequence interpretation, and experimental planning, helping scientists move faster from raw data to actionable insights. GPT-Rosalind transforms complex, time-intensive research processes into more efficient AI-assisted workflows. -
16
NVIDIA Clara
NVIDIA
Clara’s domain-specific tools, AI pre-trained models, and accelerated applications are enabling AI breakthroughs in numerous fields, including medical devices, imaging, drug discovery, and genomics. Explore the end-to-end pipeline of medical device development and deployment with the Holoscan platform. Build containerized AI apps with the Holoscan SDK and MONAI, and streamline deployment in next-generation AI devices with the NVIDIA IGX developer kits. The NVIDIA Holoscan SDK includes healthcare-specific acceleration libraries, pre-trained AI models, and reference applications for computational medical devices. -
17
IDBS Polar
IDBS
Meet IDBS Polar, the world’s first BioPharma Lifecycle Management (BPLM) platform, eliminating repetitive manual tasks, allowing you to efficiently execute your processes while curating the data you need to accelerate time to market by tackling the biggest challenges in process design, optimization, scale-up, and technology transfer. Interactive data analytics applications, such as bioreactor comparison designed specifically for biopharma development scientists. IDBS Polar is a platform that securely manages drug progression in contexts of workflow, integration, and insight. Workflows designed to simplify the BioPharma Lifecycle with process-aware planning, design, and execution of end-to-end bioprocess and analytical unit operations. Integrations that bring meaning to your data. Rapid integration into your development ecosystem, enabling automation and curating a process-centric data backbone. -
18
Kanteron
Kanteron Systems
Kanteron Platform ingested medical images, digital pathology slides, genomics sequences, and patient data from modalities, scanners, sequencers and databases, and provided a complete data toolkit to every team in hospital networks. Pharmacogenomics for adverse medication event prevention, and Precision Medicine application at the point of care: Incorporates sources of drug-gene interaction data that were previously only available in in accessible formats (e.g. tables in a PDF document), implementing the major Pharmacogenomic databases (like PharmGKB, CGI, DGIdb, OpenTargets...) Allows the user to refine their query to certain gene families, types of interactions, classes of drugs, etc. Flexible AI means you can choose the data set that best fits your use case, and apply it to your relevant medical images. -
19
prognosFACTOR
Prognos Health
The #1 source of purpose-built lab data, now with an entire ecosystem of healthcare data assets you need to answer even your most complex questions. Prognos was first to market, creating harmony between lab data types and extracting its complete analytical value in a powerful platform. Now we integrate that data with millions of medical and prescription claims in a health data marketplace and those sources are growing every day. Billions of data points at your fingertips including harmonized lab data on 325M patients, open and closed medical claims and prescription claims. Prognos Marketplace is a healthcare data marketplace that simplifies the data selection and contracting process by providing a self-service online destination where you can easily curate and purchase the health data you need when you need it. Start with the patient centric data that meets your business need. -
20
QuartzBio
QuartzBio
QuartzBio is a precision-medicine intelligence platform designed to transform how clinical development and translational research teams work by providing a unified data ecosystem where biospecimen, biomarker, and clinical data can be ingested, harmonized, explored, and interrogated via conversational AI. Powered by its Precision Medicine AI Agent Platform, QuartzBio includes key solutions like Sample Intelligence, which offers a 360° view of biospecimen lifecycles from collection to long-term storage and uses automated logistics, stability monitoring and data-reconciliation tools; and Biomarker Intelligence, which delivers unified ingestion of assay data across DNA, RNA, protein and cell-based modalities, a no-code data-mapper, global search, dashboards, visual analytics and genomic/cytometry modules; additionally, the Agent Intelligence layer enables natural-language queries across the data asset so stakeholders. -
21
Cytel
Cytel
Cytel is a leading global provider of clinical trial design software, biometric services, and advanced analytics, specializing in optimizing clinical trials and assisting pharmaceutical companies in unlocking the full potential of their clinical and real-world data. Founded in 1987 by distinguished statisticians Cyrus Mehta and Nitin Patel, Cytel has been at the forefront of adaptive clinical trial technology and biostatistical science. Our software solutions, including the East Horizon platform, empower precise trial design and simulation, utilizing adaptive and Bayesian tools to optimize protocols and accelerate drug development. The East Horizon platform integrates key components of Cytel's trusted software portfolio into a unified solution with R integration, enhancing trial design capabilities. Additionally, Cytel offers the Xact software suite, a comprehensive toolkit for statistical analyses of small datasets, and sparse, and missing data. -
22
Basesoft PharmaSuite
Basesoft
The software that will help you improve the safety, traceability, quality, agility and integration of your Pharmacotechnics and Medicines Manufacturing Unit. No two pharmacy services are the same, which is why we have divided PharmaSuite into functional modules that will help you manage the different units in the most efficient way. Management of the Pharmacotechnics and Drug Preparation unit (parenteral mixtures). Management of parenteral nutrition. -
23
Cerella
Optibrium
Proven AI-powered drug discovery. Cerella creates new value from your drug discovery data, revealing hidden insights into the best compounds and most valuable experiments for your project. It makes confident predictions, accurately filling in missing values, especially for expensive downstream experiments that can’t be predicted by other methods. This enables you to do more, even with sparse, limited data sets. -
24
Pluto
Pluto Biosciences
Since its founding in 2021 from the Wyss Institute at Harvard University, Pluto has become a trusted partner of life sciences organizations around the country ranging from biotech start-ups to public biopharma companies. Our cloud-based platform gives scientists the ability to manage all of their data, run bioinformatics analyses, and create interactive and publication-quality visualizations. The platform is currently being used for a wide variety of biological applications, from preclinical / translational science research, to cell and gene therapies, drug discovery and development, to clinical research. -
25
Saama
Saama
Actionable insights, driven by the industry's #1 AI-powered clinical analytics platform, enable your teams to manage risk and improve performance across studies, systems, sites, and vendors. State-of-the-art clintech from Saama is designed to streamline your workflows, automate time-consuming processes, and improve collaboration across clinical operations, medical review, data management, biostatistics, and pharmacovigilance. Sponsors and CROs rely on Saama for data aggregation and artificial intelligence solutions that lead to better decision-making, eliminate delays, and significantly shrink drug development costs and timelines. Saama can put you on the fast track to clinical trial process innovation. When all your clinical data is in one place and updated in real time, life’s much easier for your ClinOps and medical review teams. Data Managers have been underappreciated for too long. Eliminate manual work so they can pay attention to the data points that matter. -
26
ZONTAL
ZONTAL
ZONTAL is a leading provider of digital solutions for the life sciences industry, specializing in streamlining laboratory operations and accelerating research outcomes through integrated analytics and data science. Their comprehensive platform offers a suite of products designed to enhance data management, including the Digital Lab for connecting data and experts, Data Preservation for safeguarding valuable information, and the Life Science Analytics Platform for integrating analytics into laboratory workflows. By ensuring data is Findable, Accessible, Interoperable, and Reusable (FAIR), ZONTAL empowers organizations to eliminate data wrangling, perform instant analyses, and unlock unlimited analytics potential, thereby transforming lab operations and fostering innovation in the digital age. -
27
Healnet
Healx
Rare diseases are often not well studied and there is a limited understanding of many of the aspects necessary to support a drug discovery program. Our AI platform, Healnet, overcomes these challenges by analyzing millions of drug and disease data points to find novel connections that could be turned into new treatment opportunities. By applying frontier technologies across the discovery and development pipeline, we can run multiple stages in parallel and at scale. One disease, one target, one drug: it's an overly simple model, yet it's the one used by nearly all pharmaceutical companies. The next generation of drug discovery is AI-powered, parallel and hypothesis-free. Bringing together the key three drug discovery paradigms. -
28
BIOiSIM
VERISIMLife
BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses. Our models are built on data from thousands of compounds across 7 species, leading to robustness rarely seen in the industry. With a focus on human outcomes, the platform has at its core a translatability engine that transforms insights across species. The BIOiSIMTM platform can be used before the preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation. -
29
VeraChem
VeraChem
VeraChem LLC was founded in 2000 to advance the state of the art in computer-aided drug discovery and molecular design by developing computational chemistry methods that are based on cutting-edge basic science but are also applicable in applied science research settings. Efficient high-performance software implementations of these methods coupled with comprehensive user support are a central company strategy for product development. Current VeraChem software capabilities include protein-ligand and host-guest binding affinity prediction, fast calculation of accurate partial atomic charges for drug-like compounds, computation of energies and forces with all the commonly used empirical force fields, automatic generation of alternate resonance forms of drug-like compounds, conformational search with the powerful Tork algorithm, and automatic detection of topological and 3D molecular symmetries. VeraChem’s software packages are constructed from a modular code base. -
30
L7|ESP
L7 Informatics
L7 Enterprise Science Platform (L7|ESP®) is a unified platform that contextualizes data and eliminates business silos via process orchestration. It's a comprehensive solution that facilitates the digitalization of data and scientific processes in life sciences organizations. L7|ESP has native applications, including L7 LIMS, L7 Notebooks, L7 MES, L7 Scheduling, and more. It can integrate with existing third-party applications, lab instruments, and devices to capture all data in a single data model. It has a low-code/no-code workflow designer and hundreds of pre-built connectors to enable rapid time-to-value and end-to-end automation. By leveraging a single data model, L7|ESP enables advanced bioinformatics, AI, and ML to offer novel scientific and operational insights. L7|ESP addresses data and lab management needs in life sciences, particularly in: ● Research and Diagnostics ● Pharma and CDMO ● Clinical Sample Management Resource Center: l7informatics dot com/resource-center -
31
3decision
Discngine
3decision® is a cloud-based protein structure repository designed for comprehensive structural data management and advanced analytics, enabling small molecule and biologics discovery teams to accelerate structure-based drug design. It centralizes and standardizes experimental and in-silico protein structures from public sources like RCSB PDB and AlphaFoldDB, as well as proprietary data, supporting formats like PDBx/mmCIF and ModelCIF. This ensures easy access to X-Ray, NMR, cryo-EM, and modeled structures, fostering collaboration and enhancing research efforts. Beyond storage, 3decision® enriches entries with metadata and sequence information, including protein-ligand interactions, antibody annotations, and binding site details. Advanced analytical tools identify druggable sites, assess off-target risks, and enable binding site comparisons, transforming vast structural data into actionable knowledge. Its cloud-based platform facilitates collaboration among research teams. -
32
Synapse Medicine
Synapse
A medication intelligence platform for all healthcare professionals. Synapse Medicine is the first medication intelligence platform that allows healthcare professionals to obtain reliable medical information in real-time. Completely independent drug information for all healthcare professionals. Synapse Medicine supports all healthcare workers by ensuring correct drug use and reducing iatrogenic risks. Ensure the safety of your prescriptions with just a few clicks. Enjoy access to reliable, continuously updated medical information to support your prescription activities thanks to a platform developed by fellow physicians. A company founded by healthcare professionals. A holistic vision overview of drug information in real-time and ensure the appropriate use of medication for healthcare professionals. Supported by many institutional partners and major university hospitals. A unique medication intelligence platform. -
33
Flywheel
Flywheel
Flywheel is the pioneering medical imaging data and AI platform powering healthcare innovation through streamlined data aggregation, curation and management. By leveraging cloud scalability and automating workflows, Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payors, system integrators, AI developers and academic medical centers. Leading scientists and researchers turn to Flywheel to accelerate their work and collaborate with ease. Our medical imaging AI platform streamlines the massive tasks of data discovery, aggregation, and curation; automates research workflows; and scales on demand. -
34
AlphaFold
DeepMind
These exquisite, intricate machines are proteins. They underpin not just the biological processes in your body but every biological process in every living thing. They’re the building blocks of life. Currently, there are around 100 million known distinct proteins, with many more found every year. Each one has a unique 3D shape that determines how it works and what it does. But figuring out the exact structure of a protein remains an expensive and often time-consuming process, meaning we only know the exact 3D structure of a tiny fraction of the proteins known to science. Finding a way to close this rapidly expanding gap and predict the structure of millions of unknown proteins could not only help us tackle disease and more quickly find new medicines but perhaps also unlock the mysteries of how life itself works. -
35
Genedata Biologics
Genedata
Genedata Biologics® streamlines discovery of biotherapeutics including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. The most widely adopted platform across the industry, it integrates all discovery workflows so you can focus on true innovation. Accelerate research with a first-in-class platform uniquely designed from the start to digitalize biotherapeutic discovery. The platform facilitates complex R&D processes by designing, tracking, testing, and assessing novel biotherapeutics drugs. It works with any format, from antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, to engineered therapeutic cell lines such as TCRs and CAR-T cells. Acting as a central end-to-end data backbone, Genedata Biologics integrates all R&D processes, from library design and immunizations, selections and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, to candidate developability and manufacturability assessments. -
36
StrandOmics
Strand Life Sciences
Efficient reporting of NGS-based clinical tests requires a robust and mature platform for automatic variant prioritization, clinical interpretation and report generation. Strand Omics is a fast, HIPAA-compliant cloud-based platform that drives our clinical diagnostics practice. It has been honed over 4 years and over 10,000 clinical reports and multiple peer-reviewed publications. Strand Omics combines bioinformatics algorithms, curated databases, visualization interfaces and reporting capabilities. It has specialized workflows for both rare inherited disorders as well as somatic tumor profiling tests. The platform contains over 10,000 somatic variants curated for oncogenicity, 100 genes curated for druggability in multiple cancer types and 500 drugs curated for evidence in multiple cancer types. -
37
SpliceCore
Envisagenics
Using RNA sequencing (RNA-seq) data and Artificial Intelligence are both a necessity and an opportunity to develop therapeutics that target splicing errors. The use of machine learning enables us to discover new splicing errors and quickly design therapeutic compounds to correct them. SpliceCore is our dedicated AI platform for RNA therapeutics discovery. We developed this technology platform specifically for the analysis of RNA sequencing data. It can identify, test and validate hypothetical drug targets faster than traditional methods. At the heart of SpliceCore is our proprietary database of more than 5 million potential RNA splicing errors. It is the largest database of splicing errors in the world and it is used to test every RNA sequencing dataset that is input for analysis. Scalable cloud computing enables us to process massive amounts of RNA sequencing data efficiently, at higher speed and lower cost, exponentially accelerating therapeutic innovation. -
38
PatientIQ
PatientIQ
Founded in Chicago, Illinois, PatientIQ serves provider organizations, medical device & life sciences, and payers with its platform to learn their practice with data-driven medicine. The largest platform for healthcare professionals to collaborate and improve patient outcomes. Empower healthcare providers with industry-leading technology to practice data-driven medicine. In the U.S. healthcare market, all stakeholders are under increasing pressure to prove their value. A critical component to assessing "value" is an objective measure of patient outcomes. The challenge of measuring outcomes is expensive, nuanced, and ladened with technological barriers, but outcomes are the most valuable currency in value-based healthcare of the future. A transparent solution to systematically measure, analyze, and compare outcomes across stakeholders is the next big market opportunity in digital health. -
39
Mass Dynamics
Mass Dynamics
Discover biological biomarkers, create insights into disease mechanisms, discover new drugs or identify changes in protein levels from a set of carefully designed experiments. We’ve made it easy to start unlocking the power of MS and Proteomics so you can focus on the biological complexity and move closer to the moment of discovery. Our automated and repeatable workflow allows for quicker experiment startup and turnaround times, giving you the control and flexibility to make and act on decisions in the moment. Allowing you to focus on biological insights and human-to-human collaboration, our proteomics data processing workflow is built to scale, repeatedly. We’ve pushed heavy and repetitive processing to the cloud, enabling a seamless and enjoyable experience. Our intelligent Proteomics workflow seamlessly integrates complex moving parts to enable larger experiments to be processed and analyzed with ease. -
40
MMIT
MMIT
MMIT (Managed Markets Insight & Technology) offers a comprehensive healthcare market access and analytics platform that centralizes high-value coverage, policy, restriction, payer, and real-world data to help life sciences and healthcare organizations understand and act on how therapies are covered, reimbursed, and accessed across the U.S. healthcare system. The MMIT Platform serves as a single point of entry where users can explore integrated solutions, including formulary, medical policy, and restriction intelligence, payer landscape and enrollment data, coverage search tools, API access, and analytics, organized by workflow and strategic priority to support commercialization, competitive analysis, and patient access strategy. It provides detailed insights into drug coverage status, restriction rules, payer behavior, and market segmentation, with features that help evaluate patient access barriers, inform field engagement, predict policy shifts, and integrate coverage data. -
41
ScienceDesk
ScienceDesk
ScienceDesk data automation demystifies the use of artificial intelligence in materials sciences. A practical tool for your team to add and apply the newest AI algorithms on an everyday basis. Customizable properties, universal identifiers, QR-codes and a powerful textual-numeric search engine that links sample and experimental data. ScienceDesk is an innovative platform for scientists and engineers to interact with, collaborate on and obtain insights into their experimental data. Unfortunately, the potential of this asset is not fully exploited due to the variety of data formats and the strong dependence on experts to manually extract specific information. The ScienceDesk research data management system solves this problem by combining documentation and data analysis in a cleverly-engineered data structure. Researchers and scientists are empowered by our algorithms to gain total control of their data. They can not only share datasets, but even the analysis know-how. -
42
Sapio Scientific Data Cloud
Sapio Sciences
Sapio Scientific Data Cloud is a science-aware scientific data management system that unifies and contextualizes all your laboratory data, assay results, instrument outputs, archives, and third-party ELN/LIMS records into a single, searchable platform without any coding. It supports automated data capture and parsing from over 200 instrument adaptors, semantic search powered by ontologies, built-in charting, and advanced neural-network analytics (ANOVA, best-response curves, 4/5 PL curves, flow-cytometry gating), and AI-driven insights. Secure, role-based access and data archiving keep sensitive information safe, while protein, molecule, plasmid, and system-wide viewers let scientists explore results interactively. Deep integration with Sapio LIMS and ELN systems automatically associates data with samples, experiments, and entities. -
43
Simulations Plus
Simulations Plus
Our reputation as thought leaders in the areas of ADMET property prediction, physiologically-based pharmacokinetics (PBPK) modeling, pharmacometrics, and quantitative systems pharmacology/toxicology is earned through the success our clients have found through their relationship with us. We have the talent and 20+ years of experience to translate science into user-friendly software and provide expert consulting supporting drug discovery, clinical development research, and regulatory submissions. -
44
Bruker Drug Discovery
Bruker
Bringing a new drug into the market, from the first step to the final market introduction, is a time-consuming, highly regulated, and expensive process, which can take a decade or more. Final success crucially depends on the early availability of accurate analytical results, fast enough for taking the right decisions at the beginning of the development and minimizing late attrition rates. Today’s drug development is mainly based on a rational approach where typically establishing the biological target to focus on is the first key step. This target identification requires a deep understanding of the candidates´ properties to identify the most promising ones as quickly and reliable as possible. Once a biological target has been established, finding the most promising lead molecules is often seen as the next challenge. Typically, lead discovery is the identification of potential drug candidates – either small organic molecules or biologic assemblies with therapeutic potential. -
45
Shimadzu LabSolutions
Shimadzu Scientific Instruments
Designed to improve software operation, LabSolutions LC/GC enables simultaneous control and analysis of up to four LC/GC systems and data for a more user-friendly environment. LabSolutions DB is a SQL-based platform that integrates a data management function with LabSolutions LC/GC and is compliant with ER/ES Regulations. In addition to Shimadzu systems, other vendor’s HPLCs and GCs can also be controlled. Since all analytical data is managed in the database of a server computer, LabSolutions CS can read data from any personal computer on a network. In addition, analysis directions and instrument monitoring and control can be performed from a personal computer (client PC) not connected to the instruments. Furthermore, LabSolutions CS is compatible with Citrix XenApp and can perform advanced server management. In addition to Shimadzu chromatography and LC-MS/MS systems, LabSolutions C/S enables management of data from spectroscopy instrumentation and other vendor’s HPLCs and GCs. -
46
Uncountable
Uncountable
Uncountable helps R&D scientists move from isolated spreadsheets and projects to a comprehensive data management system the whole team can work in. Boasting the latest predictive technology and built on secure, cloud-based infrastructure, the vendor states users can develop innovative products without the hurdles and inefficiencies of yesterday. The Uncountable Platform is an enterprise solution to experiment and lab management. Combining ELN and LIMS functionality, R&D teams can manage their entire lab from within the Uncountable Platform. -
47
nuVerve
Rheolution
NuVerve is revolutionizing the way scientists work with data through its collaborative SaaS platform, offering Scientific Data Intelligence that empowers researchers across disciplines. With NuVerve, scientists gain access to a comprehensive suite of easy-to-use features designed to streamline data structuring, enable custom analyses, and facilitate the automatic generation of reports. By leveraging NuVerve's intuitive interface, researchers can efficiently organize and manipulate their data, allowing for more effective exploration and interpretation. Whether working with large datasets or complex experimental results, NuVerve provides the tools necessary to unlock insights and accelerate scientific discovery. Priced at an affordable $75 per month, NuVerve is accessible to scientists at all stages of their careers, from students and early-career researchers to seasoned professionals. Its collaborative nature fosters teamwork and knowledge sharing, facilitating collaboration bothStarting Price: $75/month -
48
Cortellis
Clarivate
Unlock hidden insights in data using the Cortellis™ suite of life science intelligence solutions – so you can make better informed decisions along the entire R&D lifecycle. We’ve removed the hard work of finding, integrating, and analyzing data so you can focus on the critical decisions needed to get your products to market faster. Applying a unique depth, breadth and quality of data that is enriched with deep domain knowledge, industry understanding, and therapeutic expertise, Cortellis unlocks hidden insights to drive data-driven decisions that accelerate innovation. Get precise, actionable answers to your specific questions across the R&D lifecycle with the broadest and deepest sources of intelligence. Accelerate innovation with Cortellis as an indispensable part of your daily workflow. -
49
StarDrop
Optibrium
With its comprehensive suite of integrated software, StarDrop™ delivers best-in-class in silico technologies within a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through predictive modeling to decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. Successful compounds require a balance of many different properties. StarDrop™ guides you through this multi-parameter optimization challenge to target compounds with the best chance of success, saving you time and resources by enabling you to synthesize and test fewer compounds. -
50
mydimed
mydimed
Preventive medicine is the future of medicine. We help healthcare providers identify and intervene with high risk patients. Helping clinicians keep patients safe. Lowering ADR inside Healthcare providers facility Between 5%-10% of hospitalized patients have an ADR during their hospitalization, an adverse event that increases risk, increases length of stay, and denies reimbursement from payers for additional hospitalization days and procedures. These Adverse Drug Reactions can be prevented. Helping ACO's, HMO's and payers to reduce preventable ER visits and hospitalization. Lowering ADR among the population with emphasis on the Elderly. Between 15%-30% of all 65+ years old patients ER visits are due to an ADR. These visits are often accompanied by hospitalization. These Adverse Drug Reactions are preventable. What We Do. Advanced Science Multi disciplinary science. Our technology is based on medical research and advanced data science, a powerful combination that yields better
